In its most recent quarter ending March 31, 2026, Doximity sustained revenue momentum supported by expansive physician network effects and AI-enabled workflow tools, confirming its position as a leading physician-focused technology platform. However, the company faces material litigation over past disclosures that imposes financial and operational overhangs. Its business model centers on monetizing broad physician engagement through Marketing, Hiring, and Workflow Solutions tailored for pharmaceutical manufacturers and health systems. The highly regulated healthcare environment, evolving compliance requirements, and customer concentration pose tangible growth constraints. Watching developments in litigation resolution and adoption rates of advanced AI features will be critical to assessing Doximity’s near-term trajectory.